Geriatric Assessments in Senior Adults With Multiple Myeloma

Completed

Conditions studied: Multiple Myeloma

In brief

This study will evaluate the prevalence of geriatric syndromes in older adults with multiple myeloma, examine relationships between baseline geriatrics syndromes and initial treatment selection, and examine risk of functional decline. Relationship between baseline geriatric questionnaires and initial treatment selection in older adults with newly diagnosed multiple myeloma. Feasibility of subjects completing the CARG geriatric assessments at baseline, 3 months and 6 months. Comorbidities or dependence in IADLs at baseline predict decline in functional status at 6 months of follow-up in older adults with newly diagnosed multiple myeloma.

Key facts

Study ID

NCT01746030

Run by

Washington University School of Medicine

People needed

42

Starts

2012-09-01

Expected to finish

2015-07-01

Last updated by the study team

2015-11-20

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must have a diagnosis of multiple myeloma by IMWF criteria: diagnosis must have occurred within 3 months of study enrollment.
• Patient must be ≥ 65 years of age.
• Patient's life expectancy must be ≥ 6 months.
• Patient must be willing to complete follow-up assessments.
• Patient must be able to understand and willing to sign a written informed consent document.

You may not qualify if…

• Patient must not have a diagnosis of smoldering myeloma.
• Patient must not have concomitant amyloidosis.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.